PCVX
$63.62-2.53%
Vaxcyte Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.02%US Stock Market 0.01%Russell 3000 0.01%
Vaxcyte Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Vaxcyte Inc. total returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $46.14 | $63.62 | 0.0% | +37.9% | |
| 2025 | $81.86 | $46.14 | 0.0% | -43.6% | |
| 2024 | $62.80 | $81.86 | 0.0% | +30.4% | |
| 2023 | $47.95 | $62.80 | 0.0% | +31.0% | |
| 2022 | $23.79 | $47.95 | 0.0% | +101.6% | |
| 2021 | $26.57 | $23.79 | 0.0% | -10.5% |
- Annualized
- +11.8%
- 2021–2026
- Average year
- +21.8%
- 5 full years
- Best year
- +101.6%
- 2022
- Worst year
- -43.6%
- 2025
- Positive years
- 3/5
- 60% up
Annualized (CAGR)
+11.8%
2021–2026
Average year
+21.8%
5 full years
Best year
+101.6%
2022
Worst year
-43.6%
2025
Positive years
3/5
60% up
Total return by period#
Annual
-100%-50%0%50%100%
2021-10%'21
2022+102%'22
2023+31%'23
2024+30%'24
2025-44%'25
2026+38%'26
Methodology#
Total returns, dividends reinvested, measured on PCVX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Vaxcyte Inc.'s average annual return?
- Since 2021, Vaxcyte Inc. (PCVX) has returned about 11.8% a year (the compound annual growth rate) and an average calendar-year return of 21.8%.
- What were Vaxcyte Inc.'s best and worst years?
- Over 2021–2026, the best year was 2022 (+101.6%) and the worst was 2025 (-43.6%).
- How often is Vaxcyte Inc. up in a year?
- 3 of the 5 full years since 2021 were positive — about 60% of the time.
More on Vaxcyte Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100